ECSP972190A - PIRIDINES REPLACED AS SELECTIVE CYCLOOXYGENASE 2 INHIBITORS - Google Patents

PIRIDINES REPLACED AS SELECTIVE CYCLOOXYGENASE 2 INHIBITORS

Info

Publication number
ECSP972190A
ECSP972190A ECSP972190A ECSP972190A EC SP972190 A ECSP972190 A EC SP972190A EC SP972190 A ECSP972190 A EC SP972190A EC SP972190 A ECSP972190 A EC SP972190A
Authority
EC
Ecuador
Prior art keywords
piridines
inhibitors
replaced
selective cyclooxygenase
formula
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Zhaoyin Wang
Jacques Yves Gauthier
Daniel Dube
Rejean Fortin
Richard Friesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42043021&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP972190(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to ECSP972190 priority Critical patent/ECSP972190A/en
Publication of ECSP972190A publication Critical patent/ECSP972190A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presnete invención abarca un compuesto de fórmula I asi como un método para el tratamiento de enfermedades mediadas por COX-2 que comprende administrar a un paciente necesitado de tal tratamiento una cantidad no-tóxica, terapéuticamente efectiva de un compuesto de la fórmula I (gráfico), la invención también abarca ciertas composiciones farmacéuticas para el tratamiento de enfermedades mediadas por COX-2 que comprende compuestos de fórmula I.The present invention encompasses a compound of formula I as well as a method for the treatment of COX-2 mediated diseases comprising administering to a patient in need of such treatment a therapeutically effective, non-toxic amount of a compound of formula I (graph ), the invention also encompasses certain pharmaceutical compositions for the treatment of COX-2 mediated diseases comprising compounds of formula I.

ECSP972190 1997-07-17 1997-07-17 PIRIDINES REPLACED AS SELECTIVE CYCLOOXYGENASE 2 INHIBITORS ECSP972190A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972190 ECSP972190A (en) 1997-07-17 1997-07-17 PIRIDINES REPLACED AS SELECTIVE CYCLOOXYGENASE 2 INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972190 ECSP972190A (en) 1997-07-17 1997-07-17 PIRIDINES REPLACED AS SELECTIVE CYCLOOXYGENASE 2 INHIBITORS

Publications (1)

Publication Number Publication Date
ECSP972190A true ECSP972190A (en) 1998-09-22

Family

ID=42043021

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972190 ECSP972190A (en) 1997-07-17 1997-07-17 PIRIDINES REPLACED AS SELECTIVE CYCLOOXYGENASE 2 INHIBITORS

Country Status (1)

Country Link
EC (1) ECSP972190A (en)

Similar Documents

Publication Publication Date Title
EA199900137A1 (en) SUBSTITUTED PYRIDINES AS A ELECTORAL CYCLOOXIGASE-2 ELECTOR INHIBITORS
ES2191069T3 (en) DIARIL-2- (5H) -FURANONAS AS COX-2 INHIBITORS.
DK0778834T3 (en) Bicyclic heterocyclic diaryl compounds as inhibitors of cyclooxygenase-2
CR11037A (en) DERIVATIVES OF 4-TETRAZOLIL -4FENYLPIPERIDINE TO TREAT PAIN (DIVISIONAL)
DK0828724T3 (en) 5-oxygenated diaryl-2- (5H) -furanones as COX-2 inhibitors
ES2165969T3 (en) AROMATIC CONDENSED NITROGEN COMPOUNDS 5.5 ARIL-SUBSTITUTED AS ANTI-INFLAMMATORY AGENTS.
ES2115237T3 (en) PHENYL HETEROCYCLES AS CYCLOOXYGENASE-2 INHIBITORS.
ES2187675T3 (en) (METILSULFONIL) PHENYL-2- (5H) -FURANONAS AS COX-2 INHIBITORS.
UY26635A1 (en) SYNERGIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
CO5160265A1 (en) ESTERES AMINOACIDOS OF RIBAVIRINA AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2186015T3 (en) DERIVATIVES OF 2- (PURIN-9-IL) -TETRAHIDROFURAN-3,4-DIOL.
EA200300776A1 (en) FENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
CY1109242T1 (en) THERAPEUTIC AGENTS USEFUL FOR PAIN TREATMENT
UY26977A1 (en) IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS
ES2146300T3 (en) USE OF ANTIHELMINTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS CAUSED BY ANOPLOCEPHALA PERFOLIATA IN EQUIDS.
DE69825603D1 (en) 2,3,5-TRISUBSTITUTED PYRIDINE AS INHIBITORS OF CYCLOOXYGENASE-2
DE69825154D1 (en) PYRIDAZINONE AS INHIBITORS OF CYCLOOXYGENASE-2
PA8542901A1 (en) USE OF (Z) -2-CIANO-3-HYDROXI-BUT-2-ENOIC ACID- (4-TRIFLUOROMETILFENIL) -AMIDA TO TREAT MULTIPLE SCLEROSIS
ES2180933T3 (en) INHIBITOR OF SERINA-PROTEASA.
DK1458393T3 (en) Substituted diketopiperazines as oxytocin antagonists
ATE386523T1 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OR PROPHYLAXIS OF DIABETES
ES2182035T3 (en) DERIVATIVES OF BISARILCICLOBUTENO AS CICLOOXIGENASA INHIBITORS
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
ATE293602T1 (en) 2-AMINOPYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2
ECSP972190A (en) PIRIDINES REPLACED AS SELECTIVE CYCLOOXYGENASE 2 INHIBITORS